The American Heart Association's company, Healthcare Quality and Research Systems, along with Laerdal Medical, have put money into MedLern, the company said in a statement. The company is a healthcare training platform that helps with both the front and back parts of educational websites and apps. 

The India-based company serves nearly 400 hospitals and over one lakh hospital workers, delivering a million hours of training through its innovative solutions in the country. The company is helping improve hospital bottom lines through driving Nursing Excellence, Service Excellence, Patient Safety, and Experience in leading hospitals in the country, it added. 

“We are seeing hospital leaders break away from an ad-hoc and just-in-time approach to training to adopt our scalable solutions. The new collaborations open up access to an impressive pipeline of healthcare training innovation. We are committed to making this affordable and rewarding for hospital leaders in India,” said Deepak Sharma, co-founder and CEO of MedLern.  

“Every year, nearly a hundred thousand Indian doctors, nurses, and other healthcare professionals are trained on the Association’s BLS, ACLS, and PALS programs but that is still a small fraction of what the country needs. With MedLern’s support, we believe we will have the scale to reach our solutions to the wider ecosystem and save many more lives. In the US, we train 22 million people in CPR every year and in the last 5 years alone, we have helped reduce deaths from stroke by 13.6 per cent and deaths from heart disease by 14.1 per cent. We are also very excited about the prospect of bringing our portfolio of evidence-based tools, guidelines, and CME content to benefit the Indian ecosystem in the future” said John Meiners, of HQRS and Chief of Mission Aligned Businesses and healthcare solutions at the American Heart Association.    
 
The investment in MedLern is made through the organization’s wholly-owned subsidiary, Healthcare Quality and Research Systems, Inc. (HQRS). 

“Globally, we achieve this through the advancement of resuscitation, patient safety and quality of healthcare, and saving lives at birth in low-resource settings. We work with enabling technologies, collaborative initiatives, and early interventions with high life-saving potential and low cost to society. Our strategic investment in ern brings us closer to bringing scalable solutions to a developing market in the most populous country in the world,” said Alf Christian Dybdahl, CEO of Laerdal Medical.    

Sameer Shariff, founder of Impelsys and chairman and co-founder of MedLern said, this is a significant step in our mission to work together to bring the best quality of global healthcare to India. I believe India has the potential to not just improve the quality of healthcare delivery to its own citizens but also contribute to the future of global healthcare.”